Carpal tunnel syndrome. Carpal tunnel syndrome
Conditions
Interventions
Intervention 1: One session of ultrasound-guided 1 CC Triamcinolone (Exir co, Tehran, Iran) injection into the carpal tunnel. Intervention 2: One session of ultrasound-guided 5 CC dextrose 5% solution
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients with clinical diagnosis of carpal tunnel syndrome (paresthesia over the median nerve territory in the hand). Mild to moderate severity of carpal tunnel syndrome, based on electrodiagnostic studies. Age between 18-65 years,
Exclusion criteria
Exclusion criteria: Severe CTS ( based on electrodiagnostic data). Signs of thenar atrophy. Contraindication for injection ( such as history of hypersensitivity to corticosteroid, signs of local infection, immune deficiency, needle phobia. Diseases that mimic symptoms of carpal tunnel syndrome such as polyneuropathy, radiculopathy, and thoracic outlet syndrome. Surgical treatment or local injection in the last six months. Neoplastic or traumatic origin. Tenderness and fracture of wrist bones.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity (Visual analogue scale). Timepoint: Baseline, and after 2 weeks, one month and 6 months after injection. Method of measurement: 10 point VAS scale.;Electrodiagnosis parameters. Timepoint: Baseline, and after 2 weeks, one month and 6 months after injection. Method of measurement: Electrodiagnostic study machine. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSara moradnia
Iran University of Medical Sciences
Outcome results
None listed